Patent ID: 8318727

Claim:
A compound of the formula: wherein R 2 is selected from the group consisting of hydrogen and (C 1-3 )alkyl; R 6 is selected from the group consisting of (C 1-5 )alkyl and (C 3-12 )cycloalkyl; y is selected from the group consisting of 0, 1, 2, and 3; each R 17 is independently selected from the group consisting of halo, nitro, cyano, hydroxy, (C 1-4 )alkoxy optionally substituted with 1 to 6 substituents independently selected from Group A, —NH 2 , —NH((C 1-10 )alkyl), —N((C 1-10 alkyl) 2 , (C 1-10 )alkyl optionally substituted with 1 to 6 substituents independently selected from Group A, and halo(C 1-10 )alkyl; R 17a is selected from the group consisting of hydrogen, halo, (C 1-4 )alkoxy optionally substituted with 1 to 6 substituents independently selected from Group A, and (C 1-10 )alkyl optionally substituted with 1 to 6 substituents independently selected from Group A; and R 17b is wherein R 19 is hydrogen; R 20 is selected from the group consisting of q is selected from the group consisting of 0, 1, 2, 3, 4 and 5; R 29 is selected from the group consisting of hydroxy, —NH 2 , —NH((C 1-10 )alkyl), —N((C 1-10 )alkyl) 2 , (C 1-4 )alkoxy, and (C 1-4 )alkyl; and R 30 is selected from the group consisting of hydrogen and (C 1-4 )alkyl; Group A is —NH 2 , —NH((C 1-10 )alkyl), —N((C 1-10 )alkyl) 2 , halo, hydroxy, nitro, oxo, cyano, (C 1-4 )alkoxy optionally substituted with 1 to 6 substituents independently selected from Group B, (C 1-4 )alkyl optionally substituted with 1 to 6 substituents independently selected from Group B, (C 3-8 )cycloalkyl optionally substituted with 1 to 5 substituents independently selected from the group consisting of Group B, hetero(C 3-12 )cycloalkyl selected from the group consisting of azetidinyl, piperidyl, morpholyl, piperazinyl, pyrrolidinyl, tetrahyrofuranyl, 1,3-dioxanyl, 1,4-dioxanyl and the hetero(C 3-12 )cycloalkyl is optionally substituted with 1 to 6 substituents independently selected from Group B, and phenyl optionally with 1 to 5 substituents independently selected from the group consisting of —NH 2 , —NH((C 1-10 )alkyl), —N((C 1-10 )alkyl) 2 , cyano, halogen, hydroxyl, nitro, C 1-4 alkyl optionally substituted with 1 to 6 substituents independently selected from Group B, and (C 1-4 )alkoxy optionally substituted with 1 to 6 substituents independently selected from Group B; Group B is —NH 2 , —NH((C 1-10 )alkyl), —N((C 1-10 )alkyl) 2 , (C 1-4 )alkoxy, (C 1-4 )alkyl, (C 3-12 )cycloalkyl(C 1-5 )alkyl, cyano, (C 3-8 )cycloalkyl, halo, hydroxy, and nitro; or a pharmaceutically acceptable salt thereof.